...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.
【24h】

Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.

机译:基于已知的脾酪氨酸激酶抑制剂的药理学模型研究,以及用于鉴定新型抑制剂的虚拟筛选。

获取原文
获取原文并翻译 | 示例
           

摘要

In this investigation, chemical features based 3D pharmacophore models were developed based on the known inhibitors of Spleen tyrosine kinase (Syk) with the aid of hiphop and hyporefine modules within catalyst. The best quantitative pharmacophore model, Hypo1, was used as a 3D structural query for retrieving potential inhibitors from chemical databases including Specs, NCI, MayBridge, and Chinese Nature Product Database (CNPD). The hit compounds were subsequently subjected to filtering by Lipinski's rule of five and docking studies to refine the retrieved hits. Finally 30 compounds were selected from the top ranked hit compounds and conducted an in vitro kinase inhibitory assay. Six compounds showed a good inhibitory potency against Syk, which have been selected for further investigation.
机译:在这项研究中,借助已知的脾酪氨酸激酶(Syk)抑制剂,借助催化剂中的hiphop和hyperrefine模块,开发了基于化学特征的3D药效团模型。最佳定量药效团模型Hypo1用作3D结构查询,可从包括Specs,NCI,MayBridge和Chinese Nature Product Database(CNPD)在内的化学数据库中检索潜在的抑制剂。命中化合物随后按照Lipinski的5条法则进行过滤,并进行对接研究以完善检索到的命中。最后,从排名靠前的命中化合物中选出30种化合物,并进行了体外激酶抑制试验。六种化合物显示出对Syk的良好抑制作用,已选择进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号